HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA
CopyKey data
Status
KRS number
REGON
NIP/VAT code
VAT registration date
VAT status
Bankruptcy proceedings
HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA
Contacts
Registered address
Website
-Reliability
Prescore cannot be calculated because the company delayed submission of financial statements.
Incorporation date
19/12/2011Share capital
No dataPrimary activity
Dispensing chemist in specialized stores (47.73.Z - PKD 2007)Representatives
0Representatives rights
WSPÓLNICY TOMASZ RYSZARD JASZCZYKOWSKI I PAWEŁ ZBIGNIEW ŻELEZIK - MOGĄ REPREZENTOWAĆ SPÓŁKĘ SAMODZIELNIE I JEDNOOSOBOWO. WSPÓLNIK KATARZYNA MARIA ŻELEZIK MOŻE REPREZENTOWAĆ SPÓŁKĘ TYLKO DZIAŁAJĄC ŁĄCZNIE ZE WSPÓLNIKIEM TOMASZEM RYSZARDEM JASZCZYKOWSKIM.Representatives
Business linkages
Compliance screening
Check whether your partner is listed in sanctions or PEP registers, or linked to negative public information or law enforcement reports. Ensure business safety and compliance.People
Representatives
Person | Title |
|---|---|
- | - |
Persons with Significant Control
Financial ratios
Net Profit (zł)
1,604,695Net Profit (zł)
1,604,695Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
| Working capital requirement (%) |
| Liquidity ratio |
| Net profitability (%) |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2021 |
|---|
| 17,420,684 |
| 2,731,271 |
| 2,731,271 |
| 0.06 |
| 1.49 |
| 15.68 |
| 3,231,271 |
| 1,982,613 |
| 207,813 |
| 322,813 |
| 2022 |
|---|
| 19,232,437 |
| 1,317,334 |
| 1,317,334 |
| 0.15 |
| 6.09 |
| 6.85 |
| 4,709,915 |
| 567,216 |
| 76,563 |
| 996,525 |
| 2023 |
|---|
| 19,979,651 |
| 1,604,695 |
| 1,604,695 |
| 0.20 |
| 8.88 |
| 8.03 |
| 4,997,276 |
| 495,146 |
| 1,195,906 |
| 1,141,744 |
| 2023 |
|---|
| 19,979,651 |
| 1,604,695 |
| 1,604,695 |
| 0.20 |
| 8.88 |
| 8.03 |
| 4,997,276 |
| 495,146 |
| 1,195,906 |
| 1,141,744 |
Turnover (zł)
2023
Turnover (zł)
19,979,651 zł4 % *
Profit before tax (zł)
1,604,695 zł22 % *
Net Profit (zł)
1,604,695 zł22 % *
Working capital requirement (%)
0.20 33.33 % *
Liquidity ratio
8.88 45.81 % *
Net profitability (%)
8.03 %17.23 % *
Equity (zł)
4,997,276 zł6 % *
Current liabilities (zł)
495,146 zł-13 % *
Non current liabilities (zł)
1,195,906 zł1,462 % *
Non-current Assets (zł)
1,141,744 zł15 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Order reportCreditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA Documents
Date | Description |
|---|---|
18/03/2026 | OD 01.01.2024 DO 31.12.2024 |
28/03/2025 | OD 01.01.2023 DO 31.12.2023 |
19/03/2024 | OD 01.01.2022 DO 31.12.2022 |
19/04/2023 | OD 01.01.2021 DO 31.12.2021 |
30/05/2022 | OD 01.01.2020 DO 31.12.2020 |
Frequently Asked Questions
What is the current status of HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA?
HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA is currently Active. It was registered on 19/12/2011.
Where is HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA located?
HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA is registered at SZKOLNA 2, 84-217, SZEMUD, POLSKA.
What does HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA do?
HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA operates in the Dispensing chemist in specialized stores (47.73.Z - PKD 2007) sector.
What is the annual turnover of HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA?
HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA reported a turnover of 19,979,651 PLN in 2023.
What is the net profit of HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA?
HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA reported a net profit of 1,604,695 PLN in 2023.
Does HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA have any unpaid debts?
HYPERPHARM DOROTA REGOSZ SPÓŁKA JAWNA has no recorded unpaid debts.